Glanbia Nutritionals has signed a partnership with India-based Aurea Biolabs, a subsidiary of Plant Lipids, to distribute two of its ingredients in the US under Glanbia’s bioactive solutions portfolio.
Mythocondro, a non-animal chondroitin sulfate (CS) marketed by Italian firm Gnosis has received novel food approval in the European Union (EU), the company has confirmed.
Gnosis is preparing to launch what it claims is the first non-animal-derived chondroitin sulphate (CS) product, Mythocondro. It says this eliminates problems with adulteration and consistency.
The UK’s Advertising Standards Authority (ASA) has warned UK firm Agora Health Ltd against making disease claims on its joint health supplements via its 'Healthier Life' information website.
Daily supplements of chondroitin sulfate may be superior to celecoxib, a potent anti-inflammatory drug, for supporting knew joint health and delaying the progression of osteoarthritis, says a new study.
ENI (Ethical Naturals Inc.) has signed a license agreement with ALS (Arkion Life Sciences) for the patents that employ a microbial fermentation process to produce N-acetyl glucosamine and glucosamine.
Joint health nutrient chondroitin varies greatly in safety and efficacy depending on its source and therefore needs greater regulation and standardisation, Canadian and Spanish researchers have said.
A combination of glucosamine hydrochloride and chondroitin sulfate may slash levels of C-reaction protein (CRP), a key biomarker of inflammation, says a new randomized, double-blind, placebo-controlled, crossover study.
Chondroitin sulfate is safe and efficacious for improving pain and functional capacity in people with osteoarthritis, says a new review from the prestigious Cochrane Collaboration.
Combining calcium fructoborate with glucosamine and chondroitin may boost measure of joint health by about 25% compared with glucosamine and chondroitin alone, says a new study from VDF Futureceuticals.
Danish firm ZPD has won EU food approval for its chondroitin sulfate – a process that has been riddled by misapprehension and prejudice, the company says.
The Czech Agriculture and Food Inspection Authority (CAFIA) says it, “repeatedly reveals serious forms of adulteration of food supplements” despite efforts through its Food Pillory system.
Efficacy, quality and smaller dosage sizes are helping suppliers of collagen ingredients gain traction in the joint health marketplace. But suppliers agree that their ingredients occupy the thin edge of the wedge, and that commodity glucosamine and chondroitin...
The emergence of multiple scientifically-supported joint health ingredients and increased consumer interest in sourcing is driving a downturn for glucosamine, but vegetable sourced versions are on the rise, says the CEO of Ethical Naturals Inc.
Two years of daily supplementation with a combination of glucosamine and a low molecular weight chondroitin sulfate may significantly reduce joint space narrowing in the knee, says a new study from the University of Sydney, Australia.
Daily supplements of BioCell Technology’s collagen-rich cartilage extract may reduce pain and other symptoms of osteoarthritis, suggest results from a randomized, double-blind, placebo-controlled trial.
Daily supplements of chondroitin sulfate may ease pain associated with osteoarthritis in the hand and reduce stiffness in the morning, according to results of the Finger osteoArthritis Chondroitin Treatment Study (FACTS).
Certain joint health supplements may offer benefits but only under certain conditions and specific doses, but there are no such question marks over safety, says a new review from Asia.
Results of a new meta-analysis into how (in)effective glucosamine and chondroitin may be for joint health has been dismissed as an ‘incomplete job’ by industry experts.
No causality has been established between glucosamine hydrochloride and a reduced rate of cartilage degeneration in individuals without osteoarthritis, according to an opinion published by the European Food Safety Authority (EFSA) on an Article 14 health...
A patented collagen ingredient may be twice as effective as glucosamine and chondroitin for joint health, according to results of randomized, double-blind study.
Industry is divided in its reaction to the recent rejection of glucosamine and joint health claims by the European Food Safety Authority (EFSA), with one manufacturer advocating a medical licensing route as an alternative way of securing claims.
Global launches of glucosamine products have risen just over 50 percent in the past five years, with the top markets remaining Asia Pacific, Europe and North America.
Extracts from the membrane of an eggshell may improve the symptoms of osteoarthritis, and offer an alternative to glucosamine and chondroitin sulphate, suggest new findings.
Chinese supplier Fenchem is diversifying its presence in the joint health sector by announcing the non-GMO (genetically modified organism) status of its sodium hyaluronate (HA) offerings.
Extracts from rosehip may reduce pain associated with osteoarthritis by 37 per cent, according to a meta-analysis of randomized controlled trials (RCTs).
The development of a new joint health drink made with glucosamine
for the US market highlights how the popular joint health
ingredient is spreading from the supplement arena to the food and
beverage category.
Triarco Industries has launched a
water-soluble, high-concentration version of liquid
glucosamine the company says is aimed at foods and beverages that
appeal to the "older" glucosamine-buying
demographic.
Researchers have associated methylsulfonylmethane, or MSM, to
protecting articular cartilage and reducing inflammation in
osteoarthritis - findings that could bolster the profile of the
ingredient for joint health.
France's Burgundy is redrawing its product catalogue to list only
innovative and differentiated products - a sea-change for the
six-year old company with its roots in the eponymous wine region.
A Spanish chondroitin sulfate manufacturer has weighed in on the
debate over the negative results of a meta-analysis recently
published in the Annals of Internal Medicine.
AOAC International has put out a call in search of a study director
for its upcoming collaborative studies on standardized methods for
joint health-supporting compound, MSM.
Unigen has been awarded a new patent on the use of free-b-ring
flavonoids from Chinese Skullcap, adding value for customers using
its Univestin ingredient in joint health products.
InterHealth's collagen ingredient UC-II performed favorably in an
study on arthritic dogs, delivering a 62 percent decrease in
overall joint pain in arthritic dogs. If the results are repeated
in humans, it could boost the ingredient...
Demand and prices for glucosamine have stabilised after a
tumultuous couple of years, as the sheen of newness rubs off the
joint health ingredient and much-anticipated GAIT trial, though
positive, proves disappointing in design.
A risk assessment for glucosamine and chondroitin sulfate, has been
authored by the CRN, providing industry and consumers with
important information on safe dosage levels.
Glucosamine and chondroitin sulfate supplements "significantly
decreased" knee pain for people suffering from moderate-to-severe
osteoarthritis - a message that may not be getting through to
consumers.
Rising consumer demand for non-prescription jointcare remedies,
backed up by new research out this year, will create a positive
climate for growth of newer entrants to the joint health sector,
believes UK company Gee Lawson.
The positive results of the GAIT and GUIDE glucosamin/chondroitin
studies are an encouraging sign for the industry, says Cargill,
which makes a non-shellfish derived, vegetarian glucosamine
hydrochloride.
Glucosamine has been shown to be one of the most effective
ingredients for promoting joint health and relieving pain, but a
new study suggests that commercial supplements may contain too
little to do any good.
